Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jounce Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price



Market Capitalization

$101.6 M


CreditSafe Score

Score changed on Jul 23, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2017FY, 2018FY, 2019FY, 2020FY, 2021FY, 2022
General and administrative expense23.1M26.4M27.9M28.8M29.0M31.0M
Operating expense total90.9M96.5M95.1M107.5M134.2M
Interest expense2.8M
Income tax expense36.0K46.0K46.0K14.0K15.0K135.0K
Net Income(16.4M)(27.4M)56.8M(43.8M)(90.9M)(50.9M)

Footer menu